Medtronic has rolled out Captivia delivery system for the Valiant Thoracic Stent Graft, a minimally invasive treatment for aneurysms and other lesions of the thoracic aorta in Canada.
The Captivia delivery system features tip capture for enhanced control of the Valiant Thoracic Stent Graft during deployment and a hydrophilic coating applied to the graft cover to facilitate iliac access and delivery through patients’ vasculature.
Medtronic claims that the new Valiant Captivia system provides physicians with ease of access and delivery, as well as deployment accuracy and control.
Endovascular Innovations, a part of the CardioVascular business at Medtronic, vice president and general manager Tony Semedo said that combined with the Valiant Thoracic Stent Graft, which retains its hallmark attribute of conformability, the new system will expand endovascular treatment to more patients with complex aortic disease.